期刊论文详细信息
| Cancer immunity | |
| Two phase I studies of low dose recombinant human IL-12 with Melan-A and influenza peptides in subjects with advanced malignant melanoma | |
| Jonathan Cebon1 | |
| [1] Ludwig Institute for Cancer Research, Melbourne, AustraliaLudwig Institute for Cancer Research, Melbourne, AustraliaLudwig Institute for Cancer Research, Melbourne, Australia | |
| 关键词: clinical trial; melanoma; IL-12; vaccination; Melan-A peptide; immunological monitoring; | |
| DOI : | |
| 学科分类：肿瘤学 | |
| 来源: Cancer immunity | |
 PDF
|
|
download
878987797
028-85220240
